Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-02-11 @ 6:57 AM
Study NCT ID:
NCT02492568
Status:
COMPLETED
Last Update Posted:
2020-08-17
First Post:
2015-06-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLC
Sponsor:
The Netherlands Cancer Institute
Organization: